Shield Therapeutics plc

Pharmaceutical Manufacturing • Gateshead, England, United Kingdom • 51-100 Employees

Company overview

Headquarters	Shield Therapeutics plc, Northern Design Centre, Gateshead Quays, NE8 3DY, GB
Phone number	+449761509
Website	shieldtherapeutics.com
NAICS	3254
SIC	873
Keywords	IBD, Anaemia, Renal Disease
Founded	2008
Employees	51-100
Socials

Key Contacts at Shield Therapeutics plc

Anders Lundstrom

Chief Executive Officer

John Wingate

East Area Sales Director

Claire Kurtz

Director, People And Culture

Ken Finn

Area Sales Director - West

Bryon Kallert

Sr. Director Fp&A

Stephanie Hicks

Director Of Corporate Operations

Shield Therapeutics plc Email Formats

Shield Therapeutics plc uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@shieldtherapeutics.com), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@shieldtherapeutics.com	100%

About Shield Therapeutics plc

Shield is a commercial stage specialty pharmaceutical company with a focus on addressing iron deficiency with its lead product Accrufer®/Feraccru® (ferric maltol). The Group has launched Accrufer® in the US and Feraccru® is commercialized in the UK and European Union by Norgine B.V., who also have the marketing rights in Australia and New Zealand. Shield also has an exclusive license agreement with Beijing Aosaikang Pharmaceutical Co., Ltd., for the development and commercialization of Accrufer® / Feraccru® in China, Hong Kong, Macau and Taiwan, with Korea Pharma Co., Ltd. in the Republic of Korea, and with KYE Pharmaceuticals Inc. in Canada.

Shield Therapeutics plc revenue & valuation

Annual revenue	$13,100,000
Revenue per employee	$199,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$41,900,000
Total funding	$6,100,000

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Manager

Director

Employees by Department

Shield Therapeutics plc has 40 employees across 8 departments.

Departments

Number of employees

Funding Data

Explore Shield Therapeutics plc's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-10-28	14	$6,100,000

Funding Insights

$6,100,000

Total funding amount

$6,100,000

Most recent funding amount

Number of funding rounds

Shield Therapeutics plc Tech Stack

Discover the technologies and tools that power Shield Therapeutics plc's digital infrastructure, from frameworks to analytics platforms.

Amazon Web Services

PaaS

reCAPTCHA

Security

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

Cookiebot

Cookie compliance

Nginx

Reverse proxies

PHP

Programming languages

Open Graph

Miscellaneous

Font Awesome

Font scripts

GSAP

JavaScript frameworks

Cookie Control

Cookie compliance

Bootstrap

UI frameworks

Frequently asked questions

Shield Therapeutics plc is located in Gateshead, England, GB.

You can reach Shield Therapeutics plc at +449761509.

Shield Therapeutics plc was founded in 2008, making it 18 years old. The company has established itself as a significant player in its industry over this time.

Shield Therapeutics plc has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

Shield Therapeutics plc has raised a total of $6,100,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.